Biological Function and Immunotherapy Utilizing Phosphatidylserine-based Nanoparticles-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Biological Function and Immunotherapy Utilizing Phosphatidylserine-based Nanoparticles

Published:2020-03-23 Issue:7 Volume:49 Page:858-874
ISSN:0882-0139
Container-title:Immunological Investigations
language:en
Short-container-title:Immunological Investigations

Author:

Glassman Fiona Y.¹²,Dingman Robert¹,Yau Helena C.³,Balu-Iyer Sathy V.¹

Affiliation:

1. Department of Pharmaceutical Sciences, University at Buffalo, the State University of New York, Buffalo, New York, USA

2. Clinical Pharmacology and Pharmacometrics, Currently at CSL Behring, King of Prussia, Pennsylvania, USA

3. Department of Film and Media Studies, Washington University in St. Louis, St. Louis, Missouri, USA

Funder

National Institutes of Health

Publisher

Informa UK Limited

Subject

General Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/08820139.2020.1738456

Reference95 articles.

1. 2006. Myozyme [package insert]. Genzyme Corporation.

2. Factor VIII therapy for hemophilia A: current and future issues

3. NADPH Oxidase-dependent Oxidation and Externalization of Phosphatidylserine during Apoptosis in Me2SO-differentiated HL-60 Cells

4. Immune tolerance induction in patients with hemophilia A

5. Immunogenicity of protein therapeutics: The key causes, consequences and challenges

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer Nanovaccines: Nanomaterials and Clinical Perspectives;Small;2024-05

2. Immune response to the components of lipid nanoparticles for ribonucleic acid therapeutics;Current Opinion in Biotechnology;2024-02

3. Biomaterial-based platforms for modulating immune components against cancer and cancer stem cells;Acta Biomaterialia;2023-04

4. Particle-Based therapies for antigen specific treatment of type 1 diabetes;International Journal of Pharmaceutics;2023-01

5. Biophysical Characterization of Tolerogenic Lipid-Based Nanoparticles Containing Phosphatidylcholine and Lysophosphatidylserine;Journal of Pharmaceutical Sciences;2022-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3